Like IT sector in the past, everything’s coming together for pharma now: GV Prasad
In the next 3-5 year there will be significant growth in our India business, our active ingredients and the services business, says GV Prasad, Co-Chairman & MD, Dr Reddy’s Laboratories. The market reaction to the settlement of the generic version of Revlimid was quite exciting. The DRL stock did cartwheels, shareholders got excited. What does … Read more